IRIS Accounts Production v24.2.0.383 10734040 director 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107340402023-04-30107340402024-04-30107340402023-05-012024-04-30107340402022-04-30107340402022-05-012023-04-30107340402023-04-3010734040ns15:EnglandWales2023-05-012024-04-3010734040ns14:PoundSterling2023-05-012024-04-3010734040ns10:Director12023-05-012024-04-3010734040ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3010734040ns10:SmallEntities2023-05-012024-04-3010734040ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3010734040ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3010734040ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3010734040ns10:FullAccounts2023-05-012024-04-3010734040ns5:CurrentFinancialInstruments2024-04-3010734040ns5:CurrentFinancialInstruments2023-04-3010734040ns5:ShareCapital2024-04-3010734040ns5:ShareCapital2023-04-3010734040ns5:RetainedEarningsAccumulatedLosses2024-04-3010734040ns5:RetainedEarningsAccumulatedLosses2023-04-3010734040ns10:RegisteredOffice2023-05-012024-04-3010734040ns5:ComputerEquipment2023-05-012024-04-3010734040ns5:ComputerEquipment2023-04-3010734040ns5:ComputerEquipment2024-04-3010734040ns5:ComputerEquipment2023-04-3010734040ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3010734040ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-30107340401ns10:Director12023-04-30107340401ns10:Director12022-04-30107340401ns10:Director12023-05-012024-04-30107340401ns10:Director12022-05-012023-04-30107340401ns10:Director12024-04-30107340401ns10:Director12023-04-30
REGISTERED NUMBER: 10734040 (England and Wales)

















EKH MEDICAL COMMUNICATIONS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024






EKH MEDICAL COMMUNICATIONS LIMITED (REGISTERED NUMBER: 10734040)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


EKH MEDICAL COMMUNICATIONS LIMITED (REGISTERED NUMBER: 10734040)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 81 427

CURRENT ASSETS
Debtors 5 6,964 2,776
Cash at bank 36,374 52,703
43,338 55,479
CREDITORS
Amounts falling due within one year 6 3,414 5,640
NET CURRENT ASSETS 39,924 49,839
TOTAL ASSETS LESS CURRENT
LIABILITIES

40,005

50,266

PROVISIONS FOR LIABILITIES 15 81
NET ASSETS 39,990 50,185

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 39,890 50,085
39,990 50,185

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the director and authorised for issue on 2 October 2024 and were signed by:



Dr E K Boyd - Director


EKH MEDICAL COMMUNICATIONS LIMITED (REGISTERED NUMBER: 10734040)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

EKH Medical Communications Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10734040

Registered office: 71 Knowl Piece
Wilbury Way
Hitchin
Hertfordshire
SG4 0TY

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. In the Director's opinion, there are no significant judgements or key sources of estimation uncertainty.

Turnover
Turnover is derived from medical services and is recognised when the services are delivered to the customer. Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


EKH MEDICAL COMMUNICATIONS LIMITED (REGISTERED NUMBER: 10734040)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 May 2023
and 30 April 2024 1,097
DEPRECIATION
At 1 May 2023 670
Charge for year 346
At 30 April 2024 1,016
NET BOOK VALUE
At 30 April 2024 81
At 30 April 2023 427

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 6,964 2,776

EKH MEDICAL COMMUNICATIONS LIMITED (REGISTERED NUMBER: 10734040)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 3,304 5,495
Other creditors 110 145
3,414 5,640

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:

2024 2023
£    £   
Dr E K Boyd
Balance outstanding at start of year (45 ) (6,880 )
Amounts advanced 24,036 25,985
Amounts repaid (24,000 ) (19,150 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (9 ) (45 )

8. RELATED PARTY DISCLOSURES

During the year, total dividends of £24,000 (2023 - £19,150) were paid to the director .

Ezzie Hutchinson is a professional name used by Ezzie Boyd a director of EKH Medical Communications Limited.